IRIS
FILICE, GAETANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.542
AS - Asia 3.557
EU - Europa 2.871
SA - Sud America 337
AF - Africa 35
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 11.356
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.474
CN - Cina 2.166
IE - Irlanda 760
SG - Singapore 725
UA - Ucraina 464
DE - Germania 358
HK - Hong Kong 350
RU - Federazione Russa 336
FI - Finlandia 297
BR - Brasile 262
SE - Svezia 199
GB - Regno Unito 133
IT - Italia 132
VN - Vietnam 121
FR - Francia 62
IN - India 43
CA - Canada 39
PL - Polonia 34
AR - Argentina 26
BD - Bangladesh 25
ES - Italia 24
JP - Giappone 24
BE - Belgio 21
MX - Messico 20
IQ - Iraq 16
EC - Ecuador 15
NL - Olanda 12
CO - Colombia 11
TR - Turchia 11
ZA - Sudafrica 11
AT - Austria 10
ID - Indonesia 9
AE - Emirati Arabi Uniti 7
AU - Australia 7
KR - Corea 7
LT - Lituania 7
IL - Israele 6
IR - Iran 6
PE - Perù 6
JO - Giordania 5
MA - Marocco 5
PY - Paraguay 5
SA - Arabia Saudita 5
AZ - Azerbaigian 4
CL - Cile 4
EU - Europa 4
KZ - Kazakistan 4
VE - Venezuela 4
AM - Armenia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
MD - Moldavia 3
MU - Mauritius 3
RO - Romania 3
TN - Tunisia 3
CH - Svizzera 2
DM - Dominica 2
DZ - Algeria 2
ET - Etiopia 2
JM - Giamaica 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
PT - Portogallo 2
SR - Suriname 2
TH - Thailandia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
KE - Kenya 1
LB - Libano 1
LV - Lettonia 1
ME - Montenegro 1
MK - Macedonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PW - Palau 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 11.354
Salva come PNG Salva come JPEG
Città #
Dublin 760
Chandler 740
Jacksonville 562
Nanjing 497
Beijing 352
Hong Kong 348
Singapore 312
Ashburn 310
Dallas 303
Boardman 237
Nanchang 215
Princeton 178
Houston 159
Lawrence 155
Changsha 150
Shenyang 145
Hebei 134
Medford 133
Wilmington 125
Los Angeles 107
Jiaxing 106
Tianjin 91
Ann Arbor 87
New York 85
Hangzhou 77
Helsinki 70
Munich 61
Shanghai 60
Buffalo 58
Moscow 52
Redondo Beach 51
Ho Chi Minh City 42
Milan 40
Hanoi 30
Turku 30
Norwalk 29
São Paulo 29
Falkenstein 25
Woodbridge 25
Tokyo 23
Verona 23
Brooklyn 22
Brussels 20
Warsaw 20
Chennai 18
The Dalles 17
Chicago 16
Fairfield 16
Seattle 16
Zhengzhou 16
Pavia 15
Montreal 14
Denver 13
Des Moines 13
Frankfurt am Main 13
Phoenix 13
Orem 12
San Francisco 12
Guangzhou 11
Kunming 11
Ningbo 11
Santa Clara 11
Jinan 10
London 10
Poplar 10
Baghdad 9
Columbus 9
Toronto 9
Falls Church 8
Haiphong 8
Mexico City 8
Orange 8
Washington 8
Atlanta 7
Boston 7
Brasília 7
Curitiba 7
Dhaka 7
Johannesburg 7
Nuremberg 7
Porto Alegre 7
Pune 7
Redwood City 7
Stockholm 7
Amsterdam 6
Belo Horizonte 6
Biên Hòa 6
Guayaquil 6
Lanzhou 6
Quito 6
Rio de Janeiro 6
Taizhou 6
Amman 5
Ankara 5
Berlin 5
Buenos Aires 5
Campinas 5
Haikou 5
Mumbai 5
Sacramento 5
Totale 7.588
Salva come PNG Salva come JPEG
Nome #
Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1 158
Aggressive daily interferon therapy in HIV-HCV coinfected patients 136
Predictors of bacterial pneumonia in Evaluation of SUbcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT). 128
The Pavia consensus statement 119
Distinct mutational drug resistance profiles of HIV-1 RNA in plasma in culture isolates of patients receiving antiretroviral theraphy 118
Booster PCR: evaluation of an improved method for amplification of a few HIV-1 proviral DNA sequences 118
Accuracy of ultrasound imaging technique for assessing lipoatrophy in HIV-infected subjects. 115
Mice and rabbits: Animal models for HIV-1 infection 108
In vitro sensitivity of 3 strains of Leptospira interrogans to 3 different antibiotics 107
Chemotherapy of toxoplasmic encephalitis in AIDS patients 107
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction. 106
Effect of teicoplanin and vancomycin on Staphylococcus aureus ultrastructure 105
Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study 104
Detection of IgG anti-HIV antibodies in mice experimentally infected with HIV-1 103
Host factors affecting the outcome of treatment of hepatitis C 103
Acute liver failure during lamivudine tratment in a hepatitis B cirrhotic patient 103
The association of "standard ELISA" and HIV (env) ELISA for detection and confirmation of HIV antibodies in human sera 102
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. 102
Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. 102
A promising cultural-biomolecular method for rapid isolation and identification of mycobacteria 100
Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection. 99
[New trends in the therapy of cryptococcosis in AIDS patients] 98
IgM-IFA, IgM-ELISA, DS-IgM-ELISA, IgM-ISAGA, performed on whole serum and IgM fractions, for detection of IgM anti-toxoplasma antibodies during pregnancy 97
A New complement fixation test for toxoplasmosis. Comparison with other serological methods 97
Life cycle of P. carinii in the lung of immuno-compromised hosts: an ultrastructural study. 97
Prevalence of HIV-1 inetgrase mutations related to resistance to dolutegravir in raltegravir naive and pretrated patients. 96
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 93
Management of hepatitis C in human immunodeficiency virus-infected patients 92
Endocytosis constitute the infectious route of HIV-1 entry in human and rabbit monocytes lacking the CD4 receptor 92
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen. 92
Transfusion-transmitted virus infection in HIV-1-seropositive patients 91
An improved method for increasing the sensitivity of direct agglutination test (D.A.T.) to the detection of IgM and IgG anti-toxoplasma antibodies 91
General issues on microbial translocation in HIV-infected patients 89
Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment 89
Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis. 88
A comparison of IHA and ELISA tests in the detection of antibodies to entamoeba histolytica 88
Comparison between IgM-IFA and DS-IgM-ELISA performed on IgM fractions and whole sera in acute acquired toxoplasmosis 86
Daily Interferon therapy in HIV-HCV coinfected patients: Preliminary Report 86
Comments on the review 'Care of patients with hepatitis C and HIV co-infection' by Soriano et al. 85
A novel methodology for large-scale phylogeny partition 85
Comparison between the complement fixation test LBCF-H100-TTE, IHAT and IgM-IFAT performed on pure IgM fractions in acute acquired and congenital toxoplasmosis 84
Point shear wave elastography method for assessing liver stiffness. 84
Rapid hepatitis B virus-DNA decay in co-infected HIV-hepatitis B virus 'eminus' patients with YMDD mutations after 4 weeks of tenofovir therapy 84
Duration of immune protection after hepatitis B vaccine in newborns from HBsAg-positive carrier mothers 84
Arterial stiffness evaluation in HIV-positive patients: a multicenter matched control study. 84
Overview on the incidence and the characteristics of HIV-related opportunistic infections and neoplasms of the heart: impact of highly active antiretroviral therapy 83
Hepatotoxicity and nelfinavir: a meta-analysis 82
Minimal invasive Treatment for Hydatid Abdominal Cysts: PAIR (Puncture, Aspiration, Injection, Reaspiration)- State of the Art 82
Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects 82
Human immunodeficiency virus (HIV): an ultrastructural study 82
[Protocols for the diagnostic verification of lymph node toxoplasmosis] 82
Could Tenofovir - Modify the Model - End-Stage Liver - Disease (MELD) Score in Patients - With End-Stage Liver Disease Eligible for Liver Transplantation? 81
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1 positive patients after commencement of a new highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER COHORT 81
Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy 81
Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV 79
Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users 79
Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy 79
Malattie Infettive 78
Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy 78
Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients. 78
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 77
Comparison of ELISA and indirect immunofluorescence in the detection of IgG and IgM antitoxoplasma antibodies 77
The morphogenesis of BLV (bovine leukemia virus) cultivated on FLK (fetal lamb kidney): an ultrastructural study 76
Detection of IgM anti-toxoplasma antibodies in acute acquired and congenital toxoplasmosis 76
Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection. 76
Practice guidelines for the treatment of hepatitis C: Recommendations from an AISF/SIMIT/SIMAST expert opinion meeting 76
A comparative ultrastructural study of the low virulent strain PV-C1/81 and RH strain cultured in A9, Vero, SIRC cell lines 76
Hepatitis B immunization in infants of hepatitis B surface antigen-negative mothers 76
Entamoebiasi e parassitosi intestinali in un centro di ricovero psichiatrico.Valutazione di efficacia di protocolli di trattamento chemioprofilattico-chemioterapeutico 75
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice. 75
Prevalence and histologic features of transfusion transmitted virus and hepatitis C virus coinfection in a group of HIV patients. 74
Detection of antibodies to p24 and gp41 epitopes of HIV by ELISA using the recombinant core protein (p24) and envelope synthetic protein (gp41). 74
Malattie Infettive 73
Recenti Acquisizioni in tema di Diagnosi,terapia e Prevenzione delle Epatiti Acute ad Etiologia Virale. 73
Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV 73
High prevalence of metabolic syndrome among HIV-infected patients: link with the cardiovascular risk 73
Pathogenesis of liver damage in HCV-HIV patients 72
Fungaemia in hospitalized patients 72
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005) 71
HIV type 1 intraperitoneal infection of rabbits permits early detection of serum antibodies to Gag, Pol, and Env proteins, neutralizing antibodies, and proviral DNA from peripheral blood mononuclear cells 71
Evolution of transmitted HIV-1 drug resistance in HIV-1 infected patients in Italy from 2000 to 2010. 71
Efficacy of a short-term amphotericin B + flucytosine combination therapy followed by itraconazole monotherapy in acute and chronic AIDS-associated cryptococcosis 71
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. 70
Pathogenesis of liver damage in HCV-HIV patients. 69
Impact of the M184V resistance mutation on virological efficacy and durability of lamivudine-based dual antiretroviral regimens as maintenance therapy in individuals with suppressed HIV-1 RNA: A cohort study 69
Prevalence of metabolic syndrome among HIV patients 69
Manuale di Virologia Clinica 68
Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure. 68
Transverse myelitis associated with Mycoplasma pneumoniae pneumonitis: a report of two cases 68
Viral excretion in the cervicovaginal secretions of HIV-1 infected women receiving antiretroviral therapy. 67
Tuberculosis meningitis in adults: 5 cases 67
Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naive patients. 67
Performance of real-time strain elastography, transient elastography, and aspartate-to-platelet ratio index in the assessment of fibrosis in chronic hepatitis C. 67
Treatment of cryptococcal meningitis in liver transplantation 67
Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patients 67
Epatocarcinoma nei soggetti HIV positivi 66
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis. 66
Quantitative assessment of cell-associated and cell-free virus in cervicovaginal samples of HIV-1-infected women 66
Epatiti Virali Acute 66
Rate of CD4+ cell count increase over periods of viral load suppressione: relationship with the number of previous virological failures. 66
Totale 8.543
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.593
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.593
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021576 0 0 0 0 0 121 10 128 32 128 123 34
2021/2022660 13 5 6 3 12 10 17 42 31 5 112 404
2022/20232.120 244 152 16 173 220 217 0 116 893 9 44 36
2023/2024641 63 126 29 38 72 166 12 54 8 17 17 39
2024/20251.774 38 180 35 60 18 69 67 124 447 40 200 496
2025/20262.350 333 337 513 499 544 124 0 0 0 0 0 0
Totale 11.512